These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2115291)

  • 1. Can storage of thawed cryoprecipitate be extended to more than six hours?
    Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
    Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.
    Soundar EP; Reyes M; Korte L; Bracey A
    Blood Transfus; 2018 Sep; 16(5):443-446. PubMed ID: 29106354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.
    Green L; Backholer L; Wiltshire M; Platton S; Stanworth SJ; Cardigan R
    Transfusion; 2016 Jun; 56(6):1356-61. PubMed ID: 27019386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing.
    Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR
    Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C.
    Spivey MA; Jeter EK; Lazarchick J; Kizer J; Spivey LB
    Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure.
    Hoffman M; Jenner P
    Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the post-thaw viability of cryoprecipitate.
    Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D
    Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
    Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
    Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures.
    Fenderson JL; Meledeo MA; Rendo MJ; Peltier GC; McIntosh CS; Davis KW; Corley JB; Cap AP
    Transfusion; 2019 Apr; 59(S2):1560-1567. PubMed ID: 30980741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 day storage period in the hospital blood bank refrigerator.
    Bahreini S; Javadzadeh Shahshahani H; Nasizadeh S; Ahmadinejad M
    Transfus Med; 2021 Dec; 31(6):494-498. PubMed ID: 34605106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Clotting Factor Activity in Fresh Frozen Plasma at Thaw with a Microwave System and after Storage at 4 degrees C for 48 Hours.
    Kuta P; Hauck-Dlimi B; Strobel J; Zimmermann R; Eckstein R
    Clin Lab; 2016; 62(6):987-91. PubMed ID: 27468559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days?
    Tholpady A; Monson J; Radovancevic R; Klein K; Bracey A
    Transfusion; 2013 Mar; 53(3):645-50. PubMed ID: 22803679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage.
    Stokol T; Parry BW
    Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen content of low-volume cryoprecipitate.
    Hoffman M; Koepke JA; Widmann FK
    Transfusion; 1987; 27(4):356-8. PubMed ID: 3111036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.